Company News - Benuvia | Controlled Substance Solutions

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗜𝗯𝗼𝗴𝗮𝗶𝗻𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁? 𝗬𝗼𝘂 𝗠𝗮𝘆 𝗕𝗲 𝗢𝘃𝗲𝗿𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗮 $50𝗠 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆

Read More
Shifting Supply Chains Prompt Growing Demand for U.S.-Based CDMO Solutions

Read More
Benuvia Operations Signs Commercial Supply Agreement with Leading U.S. Pharmaceutical Company for Dronabinol API

Read More
Benuvia Operations Signs Research & Development and Manufacturing Agreement with Trait Biosciences to Advance Next-Generation Cannabinoid-Based Products

Read More
Benuvia Operations Awarded NIH Contract for GMP Synthesis of Psilocybin and Other Bulk Drug Substances

Read More
Benuvia Operations Granted GMP Certification from Brazil National Health Surveillance Agency (ANVISA)

Read More
Benuvia Operations, LLC Enters into Licensing Agreement with Avernus Pharma for SYNDROS® CII (dronabinol) in the Gulf Cooperation Council Region

Read More
Benuvia Operations, LLC Enters into Licensing and Supply Agreements with Medra Brasil Medicamentos LTDA

Read More
Benuvia Operations, LLC and Department of Veterans Affairs Sign CRADA Agreement

Read More
Benuvia Appoints Terry Novak as New CEO

Read More
House passes Biosecure Act, sending Chinese biotech ban to Senate

Read More
Benuvia Operations, LLC Partners with Bright Green Corporation to Secure DEA-Approved Raw Materials for Pharmaceutical Innovation

Read More

Our Company Latest News & Press Releases